ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/04/02 | 1,082 | 1,093 | 1,061 | 1,069 | -13 | -1.2% | 119,700 |
2021/04/01 | 1,051 | 1,087 | 1,051 | 1,082 | +37 | +3.5% | 155,800 |
2021/03/31 | 1,035 | 1,057 | 1,035 | 1,045 | -3 | -0.3% | 164,100 |
2021/03/30 | 1,081 | 1,086 | 1,048 | 1,048 | -37 | -3.4% | 343,100 |
2021/03/29 | 1,110 | 1,141 | 1,075 | 1,085 | +3 | +0.3% | 456,500 |
2021/03/26 | 1,075 | 1,088 | 1,055 | 1,082 | +21 | +2% | 382,200 |
2021/03/25 | 1,055 | 1,222 | 1,022 | 1,061 | +48 | +4.7% | 2,426,100 |
2021/03/24 | 1,012 | 1,025 | 998 | 1,013 | +1 | +0.1% | 146,900 |
2021/03/23 | 1,040 | 1,040 | 1,008 | 1,012 | -18 | -1.7% | 155,700 |
2021/03/22 | 1,030 | 1,044 | 1,025 | 1,030 | +11 | +1.1% | 122,200 |
2021/03/19 | 1,028 | 1,028 | 1,013 | 1,019 | -9 | -0.9% | 68,200 |
2021/03/18 | 1,034 | 1,039 | 1,021 | 1,028 | -6 | -0.6% | 113,200 |
2021/03/17 | 1,010 | 1,034 | 1,007 | 1,034 | +19 | +1.9% | 85,500 |
2021/03/16 | 1,013 | 1,019 | 1,006 | 1,015 | -1 | -0.1% | 73,100 |
2021/03/15 | 1,025 | 1,028 | 1,008 | 1,016 | -9 | -0.9% | 86,800 |
2021/03/12 | 1,018 | 1,032 | 1,008 | 1,025 | +15 | +1.5% | 132,500 |
2021/03/11 | 1,012 | 1,020 | 984 | 1,010 | +13 | +1.3% | 196,900 |
2021/03/10 | 984 | 1,003 | 975 | 997 | +28 | +2.9% | 136,100 |
2021/03/09 | 967 | 973 | 942 | 969 | +2 | +0.2% | 147,500 |
2021/03/08 | 986 | 994 | 961 | 967 | -6 | -0.6% | 187,000 |
2021/03/05 | 963 | 981 | 947 | 973 | -20 | -2% | 335,800 |
2021/03/04 | 1,010 | 1,011 | 985 | 993 | -12 | -1.2% | 268,400 |
2021/03/03 | 1,043 | 1,046 | 1,003 | 1,005 | -8 | -0.8% | 174,600 |
2021/03/02 | 1,028 | 1,040 | 1,003 | 1,013 | -13 | -1.3% | 165,200 |
2021/03/01 | 1,020 | 1,040 | 1,012 | 1,026 | +8 | +0.8% | 114,700 |
2021/02/26 | 1,029 | 1,038 | 1,012 | 1,018 | -21 | -2% | 150,800 |
2021/02/25 | 1,046 | 1,055 | 1,033 | 1,039 | -1 | -0.1% | 135,000 |
2021/02/24 | 1,080 | 1,084 | 1,029 | 1,040 | -40 | -3.7% | 236,400 |
2021/02/22 | 1,081 | 1,088 | 1,066 | 1,080 | -1 | -0.1% | 128,300 |
2021/02/19 | 1,100 | 1,110 | 1,071 | 1,081 | -24 | -2.2% | 135,600 |
2021/02/18 | 1,131 | 1,149 | 1,103 | 1,105 | -17 | -1.5% | 274,400 |
2021/02/17 | 1,106 | 1,150 | 1,106 | 1,122 | +22 | +2% | 362,400 |
2021/02/16 | 1,137 | 1,155 | 1,063 | 1,100 | -49 | -4.3% | 583,600 |
2021/02/15 | 1,143 | 1,207 | 1,096 | 1,149 | -67 | -5.5% | 797,700 |
2021/02/12 | 1,251 | 1,263 | 1,212 | 1,216 | -48 | -3.8% | 379,800 |
2021/02/10 | 1,239 | 1,264 | 1,214 | 1,264 | +15 | +1.2% | 315,700 |
2021/02/09 | 1,301 | 1,301 | 1,234 | 1,249 | -51 | -3.9% | 333,800 |
2021/02/08 | 1,310 | 1,320 | 1,285 | 1,300 | -30 | -2.3% | 499,800 |
2021/02/05 | 1,321 | 1,368 | 1,316 | 1,330 | +34 | +2.6% | 615,100 |
2021/02/04 | 1,281 | 1,305 | 1,256 | 1,296 | +15 | +1.2% | 384,700 |
2021/02/03 | 1,285 | 1,312 | 1,271 | 1,281 | -3 | -0.2% | 503,300 |
2021/02/02 | 1,218 | 1,307 | 1,212 | 1,284 | +44 | +3.5% | 648,900 |
2021/02/01 | 1,293 | 1,293 | 1,201 | 1,240 | -52 | -4% | 1,062,400 |
2021/01/29 | 1,408 | 1,468 | 1,216 | 1,292 | +124 | +10.6% | 5,301,700 |
2021/01/28 | 1,140 | 1,180 | 1,137 | 1,168 | +13 | +1.1% | 198,800 |
2021/01/27 | 1,128 | 1,158 | 1,128 | 1,155 | +28 | +2.5% | 103,200 |
2021/01/26 | 1,159 | 1,163 | 1,123 | 1,127 | -32 | -2.8% | 153,800 |
2021/01/25 | 1,156 | 1,161 | 1,139 | 1,159 | +3 | +0.3% | 147,500 |
2021/01/22 | 1,107 | 1,156 | 1,098 | 1,156 | +46 | +4.1% | 298,900 |
2021/01/21 | 1,097 | 1,129 | 1,096 | 1,110 | +13 | +1.2% | 295,500 |
1001~
1050
件表示中 / 3376件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 41,400円 | +25.1% | - | 0.00% | - | 1.83倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
坪田ラボ | 40,800円 | +100.6% | - | 0.00% | 52.31倍 | 7.41倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
メディシノバ | 21,300円 | - | - | - | - | - |
|
- |
カイオム | 13,700円 | +92.3% | - | 0.00% | - | 4.88倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
NANO | 13,200円 | -20.0% | - | 0.00% | - | 3.06倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
市場注目の銘柄
チャート関連のコラム